查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1197324

腹压器械市场——增长、趋势和预测 (2023-2028)

Intra-Abdominal Pressure Measurement Devices Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 110 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

在预测期内，腹内测压设备市场预计将以 8.6% 左右的复合年增长率增长。

主要亮点

  • COVID-19 在早期阶段对压力表市场产生了重大影响，因为大流行限製或延迟了医疗设备的进出口和审批。 然而，自限制解除以来，该行业已经恢復良好。 腹内压 (IAP) 设备的增加、新产品的推出和腹腔间室综合征的高患病率促成了过去两年的市场復苏。
  • 推动市场增长的某些因素包括腹内高压 (IAH) 和腹腔间隔室综合征 (ACS) 患病率的增加以及技术进步。 根据卫生资源服务局 (HRSA) 的 2021 年报告，2021 年美国进行了 24,670 例肾臟移植手术。 此外，等待肾移植的还有90483人。
  • 在 2022 年 2 月的一篇 PubMed 论文中，肾移植后经常观察到 IAP 升高，并且与移植物功能延迟、术后并发症和肾功能恢復不足无关。事实证明它们是相关的。 IAP 的测量需要导尿，是一种方便且标准的方法。
  • 接受肾移植的患者需要 IAP 监测以检测进一步的并发症，鑑于肾移植的数量，对 IAP 测量设备的需求可能会增加，从而促进市场的增长。这是一种自然现象。
  • 根据 2022 年 1 月出版的《重症监护医学》，与非创伤中心 (NTC) 相比，在创伤中心 (TC) 中检测到 ACS 的频率更高。 根据同一消息来源，ACS 可能继发于非 NTC 中的液体超载，而预计其继发于 TC 中的休克。 此外，与 IAH 和 ACS 相关的研究活动的增加可能会在预测期内推动市场，因为它们预计会增加对 IAP 设备的需求。
  • 根据 2022 年 9 月发表在多学科数字出版研究所 (MDPI) 期刊上的一篇论文，IAH 与预后不良和手术干预需求增加相关，并伴有相关的发病率和死亡率。 发生 ACS 的创伤患者还会遭受更多的并发症、机械通气、器官衰竭和更长的住院时间。 IAH 和 ACS 在存在紧张性腹胀的情况下发展。 IAP 升高可导致组织灌注不足，导致多器官功能障碍综合征并损害几乎所有器官系统的功能。
  • IAP 监测已被证明可以显着提高重症监护室 IAH 和/或 ACS 患者的生存率。 因此，鑑于 IAP 监测的重要性，腹内测压设备市场在预测期内可能会增长。 鑑于 IAP 高血压患病率上升以及 IAP 监测的重要性，腹腔内测压设备市场在预测期内可能会增长。 然而，IPMD 在普外科的利用率很低，假阴性结果预计将在预测期内抑制市场增长。

腹腔内压力测量装置市场趋势

在预测期内，医院部门预计将占据全球腹内压设备市场的很大份额

  • 技术进步和住院时间延长等因素预计将在预测期内推动市场发展。 例如，2022 年 4 月在 PubMed 上发表的一篇论文将 IAH 确定为短期和长期死亡率以及严重器官衰竭和住院时间延长的重要且独立的预测因子。 此外，根据 2021 年 5 月发表在 Sage Journal 上的一篇论文，IAH 与 ICU 和非 ICU 患者的急性肾臟结局相关。 因此，医院系统通常为接受手术或慢性病治疗的患者使用 IAH 测量设备，以提供更好的患者护理。 因此，它能够在预测期内促进 IAP 测量设备细分市场的增长。
  • 随着医院数量的增加，对 IAH 设备的需求也将增加，从而在预测期内推动整个市场的增长。 考虑到 ICU 住院患者发生 IAP 的风险以及 IAP 测量设备的技术进步不断增加，预计 IAP 测量设备在医院的使用将增加，这有望在预测期内推动该细分市场的增长。
  • 例如，根据2022年AHA医院统计，美国共有6,093家医院，预计2022年美国所有医院将收治33,356,853人。 因此，随着入院人数的增加，ICU 单位对 IAP 测量设备的需求预计将增加，预计将在预测期内推动市场增长。
  • 技术进步和住院时间延长等因素预计将在预测期内推动市场发展。 例如，根据 2022 年 4 月发表在 PubMed 上的一篇论文，IAH 不仅是短期和长期死亡率的重要且独立的预测因子，而且还可能导致器官衰竭并导致更长的住院时间。据说这就是了 此外，根据 2021 年 5 月发表在 Sage Journal 上的一篇论文，IAH 与 ICU 和非 ICU 患者的急性肾臟结局相关。 因此，医院系统通常为接受手术或慢性病治疗的患者使用 IAH 测量设备，以提供更好的患者护理。 因此，它能够在预测期内促进 IAP 测量设备细分市场的增长。
  • 随着医院数量的增加，对 IAH 测量设备的需求也会增加，这可能会在预测期内推动整个市场的增长。 此外，根据美国医院协会（AHA）2022年医院统计，美国共有6093家医院，预计2022年美国所有医院的住院总人数为33356853人。 因此，随着入院人数的增加，ICU 单位可能需要 IAP 测量设备，这有望在预测期内推动 IAP 测量设备的市场增长。
  • 此外，根据美国癌症协会 (ACS) 2022 年的一份报告，肾癌是男性和女性最常见的 10 种癌症之一。 该报告估计，到 2022 年，女性肾癌病例可能达到 28,710 例，男性病例可能达到 50,290 例。 总体而言，男性一生中患肾癌的风险约为四分之一 (2.02%)。 对于女性，终生风险约为八分之一 (1.03%)。 因此，IAH 很可能发生在患有高危肾病的人群中，预计会导致住院治疗，这将在预测期内推动 IAP 测量设备市场的增长。
  • 鑑于 ICU 住院患者发生 IAP 的风险和 IAP 测量设备的技术进步，预计 IAP 测量设备在医院的使用将会增加，从而在预测期内推动该细分市场的增长。

北美预计在预测期内见证腹内测压设备市场的增长

  • 在北美，由于医院和门诊手术中心的快速增加、先进医疗技术的引入、慢性病患者数量的增加以及腹内高压的流行。
  • 腹腔内高压 (IAH) 和腹腔间隔室综合征 (ACS) 是重症监护病房 (ICU) 患者可能会遇到的两种并发症。 ACS 和 IAH 影响所有身体系统，尤其是心血管、呼吸、肾臟和神经系统。 因此，北美地区越来越多的慢性病可能会为 IAP 设备市场创造需求。 例如，国际癌症研究机构 (IARC) 估计，到 2040 年，加拿大将有 10,030 人患有肾癌。
  • 目前，数字 IAP 监测器常用于 ICU 中，用于对不需要医生监督的患者进行持续监测。 因此，IAP 监测设备的数字化将推进 IAP 仪表市场。 例如，在2022年6月发表在OTA杂誌上的一个案例中，介绍了MY01（NXTSENS，加拿大蒙特利尔）是一种微创设备，可以准确、连续地测量室内压力的变化。
  • 无法进行连续临床监测的 1 级创伤设施和农村地区的 ACS 管理将在很大程度上受到初步临床数据的影响。 最后，ICP 连续监测有可能成为外伤科医生和外伤患者的宝贵工具。 同样，数字压力监测器等创新设备的可用性和使用预计在不久的将来会增加对筋膜室综合症测量设备的需求。
  • 由于医院和门诊手术中心的增加、先进医疗技术的采用、腹内高压的高患病率等，预计在预测期内北美的 IAP 测量设备市场将出现增长。

腹部压力计市场竞争者分析

IAP 测量设备市场竞争激烈，由几家主要参与者组成。 公司正在采用合併、收购和合作伙伴关係等战略计划来增加其影响力。

Becton、Dickinson and Company、Medline Industries、ConvaTec Inc.、Potrero Medical、Spiegelberg GmbH 和 Stryker 等公司占有相当大的市场份额。

其他好处

  • Excel 格式的市场预测 (ME) 表
  • 三个月的分析师支持

内容

第1章介绍

  • 研究假设和市场定义
  • 调查范围

第2章研究方法论

第 3 章执行摘要

第4章市场动态

  • 市场概览
  • 市场驱动力
    • 腹内高压 (IAH) 和腹腔间隔室综合征 (ACS) 的患病率上升
    • 技术进步
  • 市场製约因素
    • IPMD 在普通外科手术中的使用减少和假阴性结果
  • 波特的五力分析
    • 新进入者的威胁
    • 买方/消费者议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分（基于价值的市场规模 - 百万美元）

  • 按产品分类
    • 消耗品
    • 设备
  • 按类型
    • 肌肉
    • 腹部
  • 最终用户
    • 医院
    • 创伤中心
    • 其他最终用户
  • 按地区
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 法国
      • 德国
      • 英国
      • 意大利
      • 西班牙
      • 其他欧洲地区
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 世界其他地区

第6章竞争格局

  • 公司简介
    • Becton, Dickinson and Company
    • Biometrix Ltd
    • Medline Industries
    • ConvaTec Inc.
    • Holtech Medical
    • Potrero Medical
    • Spiegelberg GmbH
    • Stryker Corp.
    • C2DX, Inc.

第7章 市场机会与今后动向

简介目录
Product Code: 68895

The intra-abdominal pressure measurement devices market is anticipated to register a CAGR of about 8.6% during the forecast period.

Key Highlights

  • COVID-19 significantly impacted the abdominal pressure measurement devices market during the initial phases since the import, export, and approvals of medical devices were restricted or delayed due to the pandemic. However, since the restrictions were lifted, the sector bounced back well. Over the last two years, increased intra-abdominal pressure (IAP) measurement devices, new product launches, and a high abdominal compartment syndrome prevalence have contributed to the market recovery.
  • Certain factors driving the market's growth include the increasing prevalence of intra-abdominal hypertension (IAH), abdominal compartment syndrome (ACS), and technological advancements. According to the Health Resources and Services Administration (HRSA) 2021 report, the number of people who had undergone kidney transplantation in 2021 in the United States was 24,670. In addition, there were 90,483 persons on the kidney transplant waiting list.
  • According to an article published in February 2022 in PubMed, elevated IAP was highly prevalent after kidney transplantation and was independently associated with delayed graft function, postoperative complications, and absence of renal function recovery. IAP measurement needs bladder catheterization, which is a simple, standardized method.
  • Since patients who have undergone kidney transplantation need monitoring of IAP to detect further complications and considering the number of kidney transplantations, the demand for IAP measurement devices is likely to rise, thereby boosting the market growth.
  • According to a January 2022 publication in Critical Care Medicine, ACS was detected more frequently in trauma centers (TC) than in non-trauma centers (NTC). As per the same source, ACS is more likely secondary to fluid overload in non-NTC, while it is anticipated to be secondary to shock in TC. Furthermore, increased research activities relating to IAH and ACS will likely promote the market during the forecast period since these will likely increase demand for IAP devices.
  • According to an article published in September 2022 in the Multidisciplinary Digital Publishing Institute (MDPI) Journal, IAH is associated with a poor prognosis and an increased need for surgical interventions with associated morbidity and mortality. In addition, trauma patients with ACS have more complications, mechanical ventilation, organ failure, and extended stay. IAH and ACS develop in the presence of tense abdominal distension. The rise in IAP causes tissue hypoperfusion which can lead to multiple organ dysfunction syndromes and impair the function of nearly every organ system.
  • IAP monitoring has proven to significantly improve patient survival among patients in the Intensive Care Unit with IAH and/or ACS. Hence considering the importance of IAP monitoring, the intra-abdominal pressure measurement devices market will likely witness growth over the forecast period. Given the rising prevalence of IAP hypertension and the importance of IAP monitoring, the intra-abdominal pressure measurement devices market will likely witness growth over the forecast period. However, less utilization of IPMDs in general surgery and false negative results will likely restrain the market growth over the forecast period.

Intra-Abdominal Pressure Measurement Devices Market Trends

Hospital Segment is Anticipated to Hold a Significant Share in the Global Intra-Abdominal Pressure Measurement Devices Market Over the Forecast Period

  • Factors such as technological advancements and prolonged hospital stays are anticipated to promote the market over the forecast period. For instance, according to an article published in April 2022 in PubMed, IAH is a significant and independent predictor of short- and long-term mortality, as well as severe organ failure and a prolonged hospital stay. Furthermore, as per an article published in May 2021 in Sage Journal, IAH is associated with acute renal outcomes in ICU and non-ICU patients. Hence, hospital systems typically use IAH measurement devices on patients undergoing surgery or therapy for chronic conditions to provide better care for their patients. As a result, this can boost the IAP measurement device segment growth over the forecast period.
  • As the number of hospitals increases, the demand for IAH devices increases, thereby driving the overall market growth over the forecast period. Hence, considering the risk of developing IAP in ICU-admitted patients and the increase in technological advancements in IAP measurement devices, the use of IAP measurement devices in hospitals is likely to increase, thereby boosting the market segment growth over the forecast period.
  • For instance, according to the AHA hospital statistics for 2022, the United States has 6,093 hospitals, and the total number of admissions to all US hospitals is projected to be 33,356,853 in 2022. Hence, as the number of hospital admissions increases, ICU units are likely to be in demand for IAP measurement devices, which is anticipated to boost market growth during the forecast period.
  • Factors such as technological advancements and prolonged hospital stays are anticipated to promote the market during the forecast period. For instance, according to an article published in April 2022 in PubMed, IAH is a significant and independent predictor of short- and long-term mortality, as well can cause organ failure and lead to a prolonged hospital stay. Furthermore, as per an article published in May 2021 in Sage Journal, IAH is associated with acute renal outcomes in ICU and non-ICU patients. Hence, hospital systems typically use IAH measurement devices on patients undergoing surgery or therapy for chronic conditions to provide better care for their patients. As a result, this can boost the IAP measurement device segment growth during the forecast period.
  • As the number of hospitals increases, the demand for IAH measurement devices increases, thereby driving the overall market growth during the forecast period. Furthermore, according to the American Hospital Association (AHA) hospital statistics for 2022, the United States has 6,093 hospitals, and the total number of admissions to all US hospitals is projected to be 33,356,853 in 2022. Therefore, as hospital admissions rise, ICU units are likely to need IAP measurement devices, which is expected to fuel market growth for IAP measurement devices during the the forecast period.
  • Furthermore, according to the 2022 report from the American Cancer Society (ACS), kidney cancer is among the ten most common cancers in both men and women. The same source estimated that in 2022 there would likely be 28,710 cases of kidney cancer in women and 50,290 cases in men. Overall, the lifetime risk for developing kidney cancer in men is about 1 in 46 (2.02%). The lifetime risk for women is about 1 in 80 (1.03%). Therefore, IAH is more likely to develop in people who have high-risk kidney problems, which is expected to result in hospitalization, hence, accelerating the IAP measurement devices market growth during the forecast period
  • Hence, considering the risk of developing IAP in ICU-admitted patients and the increase in technological advancements in IAP measurement devices, the use of IAP measurement devices in hospitals is likely to increase, thereby boosting the market segment growth during the forecast period.

North America is Expected to Witness a Growth in the Intra-Abdominal Pressure Measurement Devices Market Over the Forecast Period

  • North America is expected to witness growth in the intra-abdominal pressure measurement devices market owing to the rapid rise in the number of hospitals and ambulatory surgical centers, adoption of advanced medical technologies, surge in cases of chronic diseases, and prevalence of intra-abdominal hypertension.
  • Intra-abdominal hypertension (IAH) and abdominal compartment syndrome (ACS) are two complications that intensive care unit (ICU) patients potentially experience. All bodily systems, particularly the cardiovascular, respiratory, renal, and neurological systems, are impacted by ACS and IAH. Hence, the rise in chronic diseases in the North American region can create demand for the IAP devices market. For instance, according to the International Agency for Research on Cancer (IARC) estimations, the number of people affected with Kidney cancer is anticipated to be 10,030 by 2040 in Canada.
  • Digital IAP monitoring devices are now commonly used in the ICU to continuously monitor patients who do not require doctors to monitor them. Hence, digitalizing IAP monitoring devices will propel the IAP measurement devices market forward. For instance, a case study published in the OTA journal in June 2022 showed how the MY01 (NXTSENS, Montreal, Canada) is a minimally invasive device that can accurately and continuously measure changes in intra-compartmental pressure.
  • The management of ACS in level 1 trauma facilities and rural places where continuous clinical monitoring is not possible is significantly impacted by preliminary clinical data. Finally, continuous ICP monitoring has the potential to be a valuable tool for both traumatologists and trauma patients. Similarly, the availability and use of innovative instruments such as digital pressure monitors are expected to increase demand for compartment syndrome measurement devices in the near future.
  • As a result of the increase in the number of hospitals and ambulatory surgical centers, the adoption of advanced medical technologies, high prevalence of intra-abdominal hypertension, North America is expected to witness growth in the IAP measurement devices market during the forecast period.

Intra-Abdominal Pressure Measurement Devices Market Competitor Analysis

The IAP measurement devices market is competitive and consists of a few major players. Companies adopt strategic plans such as mergers, acquisitions, and collaboration in order to increase their presence.

Companies, like Becton, Dickinson and Company, Medline Industries, ConvaTec Inc., Potrero Medical, Spiegelberg GmbH, and Stryker, among others, hold a substantial market share in the market.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Prevalence of Intra-Abdominal Hypertension (IAH) and Abdominal Compartment Syndrome (ACS)
    • 4.2.2 Technological Advancements
  • 4.3 Market Restraints
    • 4.3.1 Less Utilization of IPMDs in General Surgery and False Negative Results
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD Million)

  • 5.1 By Product
    • 5.1.1 Disposables
    • 5.1.2 Equipment
  • 5.2 By Type
    • 5.2.1 Muscle
    • 5.2.2 Abdomen
  • 5.3 By End User
    • 5.3.1 Hospitals
    • 5.3.2 Trauma Centers
    • 5.3.3 Other End Users
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 France
      • 5.4.2.2 Germany
      • 5.4.2.3 United Kingdom
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Rest of the World

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Becton, Dickinson and Company
    • 6.1.2 Biometrix Ltd
    • 6.1.3 Medline Industries
    • 6.1.4 ConvaTec Inc.
    • 6.1.5 Holtech Medical
    • 6.1.6 Potrero Medical
    • 6.1.7 Spiegelberg GmbH
    • 6.1.8 Stryker Corp.
    • 6.1.9 C2DX, Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS